The Organization of Pharmaceutical Producers of India (OPPI)’s new director general, Anil Matai, sees a distinct shift in the “tone” at the helm of the Indian drug regulatory apparatus – it’s one that is “talking science, research and innovation”.
“We are clearly seeing that directionally we're moving there, and that message is percolating down [the ranks] as well. We're getting positive signals that things are changing,” said Matai in a wide-ranging interview
While the bureaucracy has its task cut out, Matai also highlighted the Indian government’s intent around backing R&D and a clear